1. Dentsply Sirona, Inc. (Ticker: XRAY)
May 3, 2016

2. Dentsply Sirona Founded in 1899 and based in York, Pennsylvania
American dental equipment and consumables producer
Became the largest professional dental company by sales after merging with Sirona in February 2016
3 segments: consumable products (30% of sales), laboratory products (10% of sales), specialty products (60% of sales)
CEO: Jeffrey T. Slovin
CFO: Ulrich Michel
COO: James G. Mosch
COO: Christopher T. Clark
Introduction
Introduce the company you are pitching: what do they produce, who is their management (experienced?, vision), what are their main revenue sources, suppliers and consumers (supplier power, consumer power).

3. Performance Current price: $59.97
Company’s stock chart
You can mention:
Current price
How has the stock performed over the past year (be ready to explain major fluctuations in the stock price)
52 week high/low
Beta of the stock
Current price: $59.97
52-week high: $ week low: $49.48
Beta: 1.35

4. Global Revenue and Growth

5. Newest in Product Line SphereTEC Filling Calibra Ceram
ORTHOPHOS SL X-ray
SIROLaser Blue
SureFil® SDR Plus

6. Risks
Global headwinds and currency fluctuations may hinder company growth
Conflicts arising from the merger of equals with Sirona may cost the company
Company may not be able to fully realize the benefits of merging with Sirona
Large number of the products are manufactured in facilities that are the sole source of such products

7. Comparables Analysis

8. Discount Cash Flow Analysis (Base)
Valuation
Provide your target price
How did you come up with this number
Use ratios/DCF to come to the conclusion.
WACC: 8.92% Price: $68.65
Five-Year Growth Rate: 5.00% Upside: 12.65%
Terminal Growth Rate: 2.00%

9. Discount Cash Flow Analysis (Bear & Bull)
Bull Case
WACC: 8.92% Price: $76.01
Five-Year Growth Rate: 5.50% Upside: 21.11%
Terminal Growth Rate: 2.00%
Bear Case
WACC: 9.00% Price: $52.91
Five-Year Growth Rate: 5.00% Upside: %
Terminal Growth Rate: 1.50%

10. Conclusion
Dentsply Sirona is currently undervalued at $ per share
Recommendation: BUY
Target price: $68.65
Questions?
Conclusion
Sum up your investment thesis
Mention target buy and sell prices
Be ready to answer questions